APOE-Targeted Therapeutics for Alzheimer’s Disease

By afschroeder • November 13, 2025

Yassine HN, Hugo C, O'Donovan B, Stephens IO, Johnson LA, Cole G, Tcw J, Johansson J, Kisler K, Chiba-Falek O. APOE-Targeted Therapeutics for Alzheimer's Disease. J Neurosci. 2025 Nov 12;45(46):e1388252025. doi: 10.1523/JNEUROSCI.1388-25.2025. PMID: 41224653.

Tags: Geriatrics, Publications, Veterans Administration

Probing effect modification by socioeconomic status in associations between blood biomarkers of neuropathology and cognitive outcomes in the United States and India

Nichols E, Kim JK, Aksman LM, Gross AL, Hu P, Kobayashi LC, Thyagarajan B, Lee J, Crimmins EM. Probing effect modification by socioeconomic status in[...]

Dextromethorphan Hydrobromide-Bupropion Hydrochloride for Agitation in Dementia: Combination or Two Stand-Alone Drugs

Brown EE, Semla T, Reuben DB. Dextromethorphan Hydrobromide-Bupropion Hydrochloride for Agitation in Dementia: Combination or Two Stand-Alone Drugs. J Am Geriatr Soc. 2026 Aug 7.[...]

Feasibility, acceptability, and usability of a novel self-monitoring program utilizing a consumer-grade wearable device paired with sleep-related patient-reported outcomes for veterans with obstructive sleep apnea

Mak S, Ghadimi S, Der-McLeod E, Naeem S, Moore V, Gil L, Chohan M, Zeidler M, Ash G, Fung C. Feasibility, acceptability, and usability of[...]